NAMSA

NAMSA is a multinational company specializing in preclinical testing to ensure medical device safety and compliance. Capabilities include materials characterization, functional and performance studies, biocompatibility testing, sterilization validation, microbial and package testing.

Clinical trials are conducted by our Biomatech (France) facility. U.S. laboratories are ISO 13485 and 17025 certified; Biomatech is accredited according to ISO 17025.

In addition, NAMSA develops, manufactures, and distributes a wide range of sterilization monitoring products including biological indicators, growth promotion test suspensions, chemical indicators and H-BAC thromboresistant coating.

Laboratories are located in the United States and France, with sales offices and distributors around the world.

RETURN TO CORPORATE LIST